ALDX
Price
$3.25
Change
+$0.16 (+5.19%)
Updated
Mar 28, 2:29 PM EST
35 days until earnings call
CRSP
Price
$68.06
Change
-$2.10 (-2.99%)
Updated
Mar 28, 2:40 PM EST
33 days until earnings call
Ad is loading...

Compare predictions ALDX vs CRSP

Header iconALDX vs CRSP Comparison
Open Charts ALDX vs CRSPBanner chart's image
Aldeyra Therapeutics
Price$3.25
Change+$0.16 (+5.19%)
Volume$600
CapitalizationN/A
CRISPR Therapeutics AG
Price$68.06
Change-$2.10 (-2.99%)
Volume$1.3K
CapitalizationN/A
View a ticker or compare two or three
ALDX vs CRSP Comparison Chart

Loading...

ALDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRSPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALDX vs. CRSP commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a StrongBuy and CRSP is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ALDX: $3.09 vs. CRSP: $70.16)
Brand notoriety: ALDX and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 62% vs. CRSP: 70%
Market capitalization -- ALDX: $181.99M vs. CRSP: $5.63B
ALDX [@Biotechnology] is valued at $181.99M. CRSP’s [@Biotechnology] market capitalization is $5.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than ALDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 6 TA indicator(s) are bullish while CRSP’s TA Score has 1 bullish TA indicator(s).

  • ALDX’s TA Score: 6 bullish, 4 bearish.
  • CRSP’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, ALDX is a better buy in the short-term than CRSP.

Price Growth

ALDX (@Biotechnology) experienced а +5.82% price change this week, while CRSP (@Biotechnology) price change was -3.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.99%. For the same industry, the average monthly price growth was +5.11%, and the average quarterly price growth was +88.90%.

Reported Earning Dates

ALDX is expected to report earnings on May 02, 2024.

CRSP is expected to report earnings on Apr 30, 2024.

Industries' Descriptions

@Biotechnology (+4.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALDX with price predictions.
OPEN
A.I.dvisor published
a Summary for CRSP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRSP($5.63B) has a higher market cap than ALDX($182M). CRSP YTD gains are higher at: 12.077 vs. ALDX (-11.966). ALDX has higher annual earnings (EBITDA): -35.21M vs. CRSP (-202.7M). CRSP has more cash in the bank: 1.69B vs. ALDX (143M). ALDX has less debt than CRSP: ALDX (15.7M) vs CRSP (239M). CRSP has higher revenues than ALDX: CRSP (370M) vs ALDX (0).
ALDXCRSPALDX / CRSP
Capitalization182M5.63B3%
EBITDA-35.21M-202.7M17%
Gain YTD-11.96612.077-99%
P/E RatioN/A20.92-
Revenue0370M-
Total Cash143M1.69B8%
Total Debt15.7M239M7%
FUNDAMENTALS RATINGS
ALDX vs CRSP: Fundamental Ratings
ALDX
CRSP
OUTLOOK RATING
1..100
6751
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10076
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
8546
P/E GROWTH RATING
1..100
10082
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (23) in the Biotechnology industry is somewhat better than the same rating for CRSP (62). This means that ALDX’s stock grew somewhat faster than CRSP’s over the last 12 months.

CRSP's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as ALDX (100). This means that CRSP’s stock grew similarly to ALDX’s over the last 12 months.

CRSP's SMR Rating (93) in the Biotechnology industry is in the same range as ALDX (96). This means that CRSP’s stock grew similarly to ALDX’s over the last 12 months.

CRSP's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for ALDX (85). This means that CRSP’s stock grew somewhat faster than ALDX’s over the last 12 months.

CRSP's P/E Growth Rating (82) in the Biotechnology industry is in the same range as ALDX (100). This means that CRSP’s stock grew similarly to ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXCRSP
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
ALDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRSPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RVVHX10.610.22
+2.12%
Royce Small-Cap Value Investment
PGVFX32.760.26
+0.80%
Polaris Global Value
JHDAX16.740.03
+0.18%
JPMorgan Hedged Equity 2 A
MXBUX9.27N/A
N/A
Empower S&P Mid Cap 400® Index L
BKSIX10.17N/A
N/A
BlackRock Sustainable Intntl Eq K